Similar articles

• Tolmetin: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.

  Brogden RN, Heel RC, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1978 Jun;15(6):429-50. doi: 10.2165/00003495-197815060-00002. Drugs. 1978. PMID: 350558 Review. No abstract available.
• Tolmetin: an evaluation of a new preparation in the treatment of rheumatoid arthritis.

  Bain LS, el-Ghobarey AF, Collins RM, Sargent NW. Bain LS, et al. Br J Clin Pract. 1975 Aug;29(8):208-10. Br J Clin Pract. 1975. PMID: 1100086 Clinical Trial. No abstract available.
• [1st data related to the study of a new drug. Tolmetin, in the treatment of rheumatoid arthritis. Preliminary communication].

  Pavelka K, Susta A. Pavelka K, et al. Clin Ter. 1975 Oct 15;75(1):13-6. Clin Ter. 1975. PMID: 776502 Clinical Trial. Italian. No abstract available.
• [Drug evaluation of McN-2559 in chronic rheumatoid arthritis].

  Shiokawa Y, Yamamoto M, Onoda D, Iwasaki Y. Shiokawa Y, et al. Ryumachi. 1977 Jan;17(1):80-8. Ryumachi. 1977. PMID: 322319 Clinical Trial. Japanese. No abstract available.
• The pharmacokinetic and metabolic profile of the antiinflammatory agent tolmetin in laboratory animals and man.

  Grindel JM. Grindel JM. Drug Metab Rev. 1981;12(2):363-77. doi: 10.3109/03602538108994037. Drug Metab Rev. 1981. PMID: 7040019 Review. No abstract available.